Australian Pharmaceutical Industries Ltd
ASX:API
Australian Pharmaceutical Industries Ltd
Long-Term Debt
Australian Pharmaceutical Industries Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Australian Pharmaceutical Industries Ltd
ASX:API
|
Long-Term Debt
AU$246.9m
|
CAGR 3-Years
40%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Paragon Care Ltd
ASX:PGC
|
Long-Term Debt
AU$119.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
33%
|
|
|
Sigma Healthcare Ltd
ASX:SIG
|
Long-Term Debt
AU$1.9B
|
CAGR 3-Years
101%
|
CAGR 5-Years
117%
|
CAGR 10-Years
150%
|
|
Australian Pharmaceutical Industries Ltd
Glance View
Australian Pharmaceutical Industries Ltd. engages in the wholesale, product delivery, retail services, marketing programs and business advisory services. The company is headquartered in Melbourne, Victoria. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The firm's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.
See Also
What is Australian Pharmaceutical Industries Ltd's Long-Term Debt?
Long-Term Debt
246.9m
AUD
Based on the financial report for Aug 31, 2021, Australian Pharmaceutical Industries Ltd's Long-Term Debt amounts to 246.9m AUD.
What is Australian Pharmaceutical Industries Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
39%
Over the last year, the Long-Term Debt growth was 16%. The average annual Long-Term Debt growth rates for Australian Pharmaceutical Industries Ltd have been 40% over the past three years , 39% over the past five years .
